ST
ICPT

Spot Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Spot Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,500
Closed -$415K – 4185
2015
Q3 		$415K Buy
+2,500
New +$550K ﹤0.01% 2186
2015
Q1 		– Sell
-26
Closed -$4K – 4416
2014
Q4 		$4K Buy
+26
New +$4.8K ﹤0.01% 3794
2014
Q3 		– Sell
-27
Closed -$6K – 4807
2014
Q2 		$6K Buy
+27
New +$7.12K ﹤0.01% 4342

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Spot Trading's ICPT Position: Q4 2015 in Review

Spot Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2015, closing a stake of 2,500 shares — an estimated $415K sold.

Spot Trading first reported a position in ICPT in Q2 2014 and held it in 3 quarters. The position peaked at $415K in Q3 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q4 2015.

  • Spot Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Spot Trading sold 2,500 Intercept Pharmaceuticals, Inc. shares in Q4 2015, an estimated $415K.
  • Spot Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
  • Spot Trading's Intercept Pharmaceuticals, Inc. position peaked at $415K in Q3 2015.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2015.

Based on Spot Trading's 13F filing for Q4 2015, filed 29 Jan 2016.